• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

m6A RNA 甲基化与其他表观遗传调控因子的串扰:表观遗传重塑的新视角。

The crosstalk between mA RNA methylation and other epigenetic regulators: a novel perspective in epigenetic remodeling.

机构信息

Department of Pathology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, 310000, China.

Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310000, China.

出版信息

Theranostics. 2021 Mar 4;11(9):4549-4566. doi: 10.7150/thno.54967. eCollection 2021.

DOI:10.7150/thno.54967
PMID:33754077
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7977459/
Abstract

Epigenetic regulation involves a range of sophisticated processes which contribute to heritable alterations in gene expression without altering DNA sequence. Regulatory events predominantly include DNA methylation, chromatin remodeling, histone modifications, non-coding RNAs (ncRNAs), and RNA modification. As the most prevalent RNA modification in eukaryotic cells, N-methyladenosine (mA) RNA methylation actively participates in the modulation of RNA metabolism. Notably, accumulating evidence has revealed complicated interrelations occurring between mA and other well-known epigenetic modifications. Their crosstalk conspicuously triggers epigenetic remodeling, further yielding profound impacts on a variety of physiological and pathological processes, especially tumorigenesis. Herein, we provide an up-to-date review of this emerging hot area of biological research, summarizing the interplay between mA RNA methylation and other epigenetic regulators, and highlighting their underlying functions in epigenetic reprogramming.

摘要

表观遗传调控涉及一系列复杂的过程,这些过程有助于基因表达的可遗传改变,而不会改变 DNA 序列。调节事件主要包括 DNA 甲基化、染色质重塑、组蛋白修饰、非编码 RNA(ncRNA)和 RNA 修饰。作为真核细胞中最普遍的 RNA 修饰,N6-甲基腺苷(m6A)RNA 甲基化积极参与 RNA 代谢的调节。值得注意的是,越来越多的证据表明 m6A 与其他著名的表观遗传修饰之间存在复杂的相互关系。它们的串扰显著引发表观遗传重塑,进一步对多种生理和病理过程产生深远影响,特别是肿瘤发生。本文就这一新兴的生物学研究热点领域进行了综述,总结了 m6A RNA 甲基化与其他表观遗传调控因子之间的相互作用,并强调了它们在表观遗传重编程中的潜在功能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e1c/7977459/8e8d2ea14a27/thnov11p4549g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e1c/7977459/ad3218691808/thnov11p4549g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e1c/7977459/4c40c79f7c69/thnov11p4549g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e1c/7977459/8e8d2ea14a27/thnov11p4549g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e1c/7977459/ad3218691808/thnov11p4549g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e1c/7977459/4c40c79f7c69/thnov11p4549g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e1c/7977459/8e8d2ea14a27/thnov11p4549g003.jpg

相似文献

1
The crosstalk between mA RNA methylation and other epigenetic regulators: a novel perspective in epigenetic remodeling.m6A RNA 甲基化与其他表观遗传调控因子的串扰:表观遗传重塑的新视角。
Theranostics. 2021 Mar 4;11(9):4549-4566. doi: 10.7150/thno.54967. eCollection 2021.
2
Crosstalk between histone/DNA modifications and RNA N-methyladenosine modification.组蛋白/DNA 修饰与 RNA N6-甲基腺苷修饰的串扰。
Curr Opin Genet Dev. 2024 Jun;86:102205. doi: 10.1016/j.gde.2024.102205. Epub 2024 May 21.
3
Epigenetic N6-methyladenosine modification of RNA and DNA regulates cancer.RNA 和 DNA 的表观遗传 N6-甲基腺苷修饰调节癌症。
Cancer Biol Med. 2020 Feb 15;17(1):9-19. doi: 10.20892/j.issn.2095-3941.2019.0347.
4
Transgenerational inheritance: how impacts to the epigenetic and genetic information of parents affect offspring health.跨代遗传:父母的表观遗传和遗传信息如何影响后代的健康。
Hum Reprod Update. 2019 Sep 11;25(5):518-540. doi: 10.1093/humupd/dmz017.
5
Regulation of RNA N-methyladenosine modification and its emerging roles in skeletal muscle development.RNA N6-甲基腺苷修饰的调控及其在骨骼肌发育中的新兴作用。
Int J Biol Sci. 2021 Apr 12;17(7):1682-1692. doi: 10.7150/ijbs.56251. eCollection 2021.
6
m6A epitranscriptomic and epigenetic crosstalk in liver fibrosis: Special emphasis on DNA methylation and non-coding RNAs.m6A 表观转录组学和肝纤维化中的表观遗传学相互作用:特别强调 DNA 甲基化和非编码 RNA。
Cell Signal. 2024 Oct;122:111302. doi: 10.1016/j.cellsig.2024.111302. Epub 2024 Jul 25.
7
Non-coding RNA-linked epigenetic regulation in cardiac hypertrophy.非编码 RNA 相关的心脏肥大中的表观遗传调控。
Int J Biol Sci. 2018 Jun 22;14(9):1133-1141. doi: 10.7150/ijbs.26215. eCollection 2018.
8
Alterations of Epigenetic Regulators in Pancreatic Cancer and Their Clinical Implications.胰腺癌中表观遗传调控因子的改变及其临床意义
Int J Mol Sci. 2016 Dec 19;17(12):2138. doi: 10.3390/ijms17122138.
9
A systematic review of epigenetic interplay in kidney diseases: Crosstalk between long noncoding RNAs and methylation, acetylation of chromatin and histone.系统综述肾脏疾病中的表观遗传相互作用:长非编码 RNA 与染色质甲基化、乙酰化和组蛋白之间的串扰。
Biomed Pharmacother. 2024 Jul;176:116922. doi: 10.1016/j.biopha.2024.116922. Epub 2024 Jun 12.
10
Novel Insights Into the Role of N6-Methyladenosine RNA Modification in Bone Pathophysiology.N6-甲基腺苷 RNA 修饰在骨病理生理学中的作用的新见解。
Stem Cells Dev. 2021 Jan 1;30(1):17-28. doi: 10.1089/scd.2020.0157. Epub 2020 Dec 21.

引用本文的文献

1
The role of N6-methyladenosine (mA) RNA methylation modification in kidney diseases: from mechanism to therapeutic potential.N6-甲基腺苷(m⁶A)RNA甲基化修饰在肾脏疾病中的作用:从机制到治疗潜力
PeerJ. 2025 Aug 27;13:e19940. doi: 10.7717/peerj.19940. eCollection 2025.
2
Targeting epigenetic modifications as an emerging immunotherapeutic strategy for cancers.将表观遗传修饰作为一种新兴的癌症免疫治疗策略。
Immunol Res. 2025 Aug 19;73(1):121. doi: 10.1007/s12026-025-09678-7.
3
Targeting epigenetic regulators as a promising avenue to overcome cancer therapy resistance.

本文引用的文献

1
mA-RNA Demethylase FTO Inhibitors Impair Self-Renewal in Glioblastoma Stem Cells.mA-RNA 去甲基酶 FTO 抑制剂可破坏神经胶质瘤干细胞的自我更新。
ACS Chem Biol. 2021 Feb 19;16(2):324-333. doi: 10.1021/acschembio.0c00841. Epub 2021 Jan 7.
2
Histone deacetylase inhibitor MPT0B291 suppresses Glioma Growth and partially through acetylation of p53.组蛋白去乙酰化酶抑制剂 MPT0B291 抑制神经胶质瘤生长,部分通过乙酰化 p53 实现。
Int J Biol Sci. 2020 Oct 19;16(16):3184-3199. doi: 10.7150/ijbs.45505. eCollection 2020.
3
The Mammalian Cap-Specific mAm RNA Methyltransferase PCIF1 Regulates Transcript Levels in Mouse Tissues.
将表观遗传调节因子作为克服癌症治疗耐药性的一条有前景的途径。
Signal Transduct Target Ther. 2025 Jul 18;10(1):219. doi: 10.1038/s41392-025-02266-z.
4
Epitranscriptomic modifications for enhancing abiotic stress resistance in plants.用于增强植物非生物胁迫抗性的表观转录组修饰
Front Plant Sci. 2025 May 23;16:1538664. doi: 10.3389/fpls.2025.1538664. eCollection 2025.
5
BARD1-mediated stabilization of METTL14 promotes retinal neovascularization by m6A-modifying MXD1 mRNA on a YTHDF2-dependent manner.BARD1介导的METTL14稳定通过以YTHDF2依赖的方式对MXD1 mRNA进行m6A修饰来促进视网膜新生血管形成。
Theranostics. 2025 Apr 13;15(11):5481-5498. doi: 10.7150/thno.110122. eCollection 2025.
6
The impact of dysregulation SUMOylation on prostate cancer.SUMO化失调对前列腺癌的影响。
J Transl Med. 2025 Mar 6;23(1):286. doi: 10.1186/s12967-025-06271-2.
7
Cis-Regulation of an mA Eraser by an Insertion Variant Associated with Survival of Patients With Non-Small Cell Lung Carcinoma.与非小细胞肺癌患者生存相关的插入变异对mA去甲基化酶的顺式调控
Adv Sci (Weinh). 2025 Feb;12(5):e2407652. doi: 10.1002/advs.202407652. Epub 2024 Dec 16.
8
The SUMO Family: Mechanisms and Implications in Thyroid Cancer Pathogenesis and Therapy.SUMO家族:在甲状腺癌发病机制与治疗中的作用机制及意义
Biomedicines. 2024 Oct 21;12(10):2408. doi: 10.3390/biomedicines12102408.
9
Emerging Orchestrator of Ecological Adaptation: mA Regulation of Post-Transcriptional Mechanisms.生态适应的新兴调控因子:转录后机制的 mA 调控
Mol Ecol. 2024 Oct 5:e17545. doi: 10.1111/mec.17545.
10
Regulatory role of N6-Methyladenosine on skeletal muscle development in Hu sheep.N6-甲基腺嘌呤对湖羊骨骼肌发育的调控作用
Front Genet. 2024 Aug 21;15:1449144. doi: 10.3389/fgene.2024.1449144. eCollection 2024.
哺乳动物帽特异性 mAm RNA 甲基转移酶 PCIF1 调节小鼠组织中的转录水平。
Cell Rep. 2020 Aug 18;32(7):108038. doi: 10.1016/j.celrep.2020.108038.
4
N-Methyladenosine co-transcriptionally directs the demethylation of histone H3K9me2.N6-甲基腺苷共转录指导组蛋白 H3K9me2 的去甲基化。
Nat Genet. 2020 Sep;52(9):870-877. doi: 10.1038/s41588-020-0677-3. Epub 2020 Aug 10.
5
RNA Editing and Modifications in Mood Disorders.心境障碍中的 RNA 编辑与修饰。
Genes (Basel). 2020 Jul 31;11(8):872. doi: 10.3390/genes11080872.
6
ALKBH5 regulates anti-PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment.ALKBH5 通过调节肿瘤微环境中的乳酸和抑制性免疫细胞积累来调控抗 PD-1 治疗反应。
Proc Natl Acad Sci U S A. 2020 Aug 18;117(33):20159-20170. doi: 10.1073/pnas.1918986117. Epub 2020 Aug 3.
7
METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.METTL14 通过介导 SOX4 mRNA 的 N6-甲基腺苷修饰抑制结直肠癌的肿瘤转移。
Mol Cancer. 2020 Jun 17;19(1):106. doi: 10.1186/s12943-020-01220-7.
8
Epigenetic modulation combined with PD-1/PD-L1 blockade enhances immunotherapy based on MAGE-A11 antigen-specific CD8+T cells against esophageal carcinoma.表观遗传调控联合 PD-1/PD-L1 阻断增强基于 MAGE-A11 抗原特异性 CD8+T 细胞的免疫治疗食管癌。
Carcinogenesis. 2020 Jul 14;41(7):894-903. doi: 10.1093/carcin/bgaa057.
9
A Unified Model for the Function of YTHDF Proteins in Regulating mA-Modified mRNA.YTHDF 蛋白在调节 mA 修饰 mRNA 功能中的统一模型
Cell. 2020 Jun 25;181(7):1582-1595.e18. doi: 10.1016/j.cell.2020.05.012. Epub 2020 Jun 2.
10
Modulation of circRNA Metabolism by mA Modification.mRNA mA 修饰调控环状 RNA 代谢。
Cell Rep. 2020 May 12;31(6):107641. doi: 10.1016/j.celrep.2020.107641.